Product How it works Pricing Blog FAQ About Contact
Vertex Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ: VRTX) free cash flow

Vertex Pharmaceuticals reported free cash flow of $3,194m for fiscal 2025: $3,631m of operating cash flow minus $437.6m of capital expenditure. It equals 26.6% of revenue.

Free cash flow, in millions of US dollars179.52016745.520171,17520181,49420192,99420202,40920213,92520223,3372023-790.320243,1942025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Free cash flow by fiscal year

Fiscal yearFree cash flowChangeOperating cash flowCapital expenditureShare of revenue
2025$3,194m—$3,631m$437.6m26.6%
2024−$790.3m−123.7%−$492.6m$297.7m−7.2%
2023$3,337m−15.0%$3,537m$200.4m33.8%
2022$3,925m+63.0%$4,130m$204.7m44.0%
2021$2,409m−19.5%$2,644m$235.0m31.8%
2020$2,994m+100.4%$3,254m$259.8m48.2%
2019$1,494m+27.2%$1,569m$75.4m35.9%
2018$1,175m+57.6%$1,270m$95.4m38.5%
2017$745.5m+315.2%$844.9m$99.4m30.0%
2016$179.5m—$236.1m$56.6m10.5%

Free cash flow is operating cash flow minus capital expenditure, both from the cash flow statement in the same filing. The change compares each fiscal year with the one before and is not calculated when the previous year was negative. Figures are in millions of US dollars, except per-share amounts.

Questions about the free cash flow of Vertex Pharmaceuticals

How much free cash flow did Vertex Pharmaceuticals generate in fiscal 2025?
Vertex Pharmaceuticals reported free cash flow of $3,194m for fiscal 2025. In fiscal 2024 it was negative free cash flow of $790.3m.
How is the free cash flow of Vertex Pharmaceuticals calculated?
It is operating cash flow minus capital expenditure, both from the cash flow statement in its accounts: in fiscal 2025, $3,631m minus $437.6m.
What share of its revenue does Vertex Pharmaceuticals turn into free cash flow?
In fiscal 2025, 26.6% of its revenue.
What was the best year for free cash flow at Vertex Pharmaceuticals?
Of its last 10 fiscal years, fiscal 2022, with $3,925m.
Where do the figures for Vertex Pharmaceuticals come from?
From the annual report (Form 10-K) that Vertex Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Vertex Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Vertex Pharmaceuticals: the Vertex Pharmaceuticals page · annual accounts · revenue · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.